Related Experiment Video
Updated: May 15, 2026
08:44
A High-Throughput In Situ Method for Estimation of Hepatocyte Nuclear Ploidy in Mice
Published on: April 19, 2020
Somatic second-hit mutations leads to polycystic liver diseases
World Journal of Gastroenterology
|January 18, 2013
Summary
Polycystic liver diseases (PCLDs) involve liver cyst development. Research shows autosomal dominant polycystic liver disease (ADPLD) often requires a second mutation, highlighting hepatocystin
Area of Science:
- Genetics and Molecular Biology
- Hepatology and Gastroenterology
- Cell Biology
Background:
- Polycystic liver diseases (PCLDs) are genetic disorders causing liver cysts from cholangiocytes.
- Symptoms include abdominal distension and pain; PCLDs can be isolated or with kidney cysts.
- Prevalence is estimated at 1:1000, with complex genetic underpinnings.
Discussion:
- Hepatic cystogenesis in dominant PCLDs may involve somatic loss of heterozygosity (LOH).
- A study on autosomal dominant polycystic liver disease (ADPLD) found a second somatic mutation is often required.
- This suggests PCLD is recessive at the cellular level, with hepatocystin loss being crucial.
Key Insights:
- Patients with germline mutations in PRKCSH (encoding hepatocystin) develop cysts via a second somatic mutation.
- Hepatic cysts with LOH showed absent hepatocystin, while heterozygous cysts retained expression.
- No additional mutations were found in the SEC63 gene in these ADPLD cases.
Outlook:
- Understanding the role of somatic second-hit mutations is key to deciphering PCLD pathogenesis.
- Further research into hepatocystin's function and loss is critical for therapeutic strategies.
- Investigating SEC63's role and interactions may reveal additional pathways in PCLD development.
Related Concept Videos
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...